
![]() | Read in Browser | |||||||||
![]() | ||||||||||
![]() | ||||||||||
|
The companies Barron's highlights are: Acceleron Pharma (NASDAQ:XLRN), Invitae (NYSE:NVTA), Sarepta Therapeutics (NASDAQ:SRPT), COMPASS Pathways (NASDAQ:CMPS), and AlloVir (NASDAQ:ALVR). (34 comments) Qualcomm (NASDAQ:QCOM) to supply chip for new Renault (OTC:RNSDF) electric vehicle.
Japan to purchase 150M doses of Novavax's (NASDAQ:NVAX) COVID-19 vaccine.
FDA places clinical hold on BioMarin's (NASDAQ:BMRN) Phase 1/2 gene therapy study in phenylketonuria.
HUYA's (NYSE:HUYA) chief financial officer resigns.
111 (NASDAQ:YI) approves $10M share repurchase program.
Deutsche Telekom (OTCQX:DTEGF) nears €5B sale of Dutch unit - Bloomberg.
Download Seeking Alpha for your Phone or Tablet
Want More Ideas?
Our best ideas → Stock Ideas
ETF's Investing Ideas → ETF Ideas
Dividend stocks ideas → Dividend Ideas
This email was sent to you because you signed up to receive Wall Street Breakfast.
If you do not want to receive Wall Street Breakfast emails, click here to unsubscribe.
Sent by Seeking Alpha, 52 Vanderbilt Avenue, 13th floor, New York, NY 10017
Covid
White House chief medical advisor Dr. Anthony Fauci says that the U.S. COVID-19 vaccine rollout scheduled for Sept. 20 will likely start with Pfizer (NYSE:PFE)/ BioNTech (NASDAQ:BNTX) COVID-19 vaccine, soon followed by the introduction of Moderna (NASDAQ:MRNA) COVID-19 booster shot.
Speaking on CBS' "Face the Nation," on Sunday, the top U.S. infectious disease expert said Pfizer/ BioNTech have likely submitted sufficient data for regulators to make a decision before the deadline, set by The White House last month. "It is conceivable that we will only have one of them out, but the other will likely follow soon thereafter," Fauci said. (158 comments)
Speaking on CBS' "Face the Nation," on Sunday, the top U.S. infectious disease expert said Pfizer/ BioNTech have likely submitted sufficient data for regulators to make a decision before the deadline, set by The White House last month. "It is conceivable that we will only have one of them out, but the other will likely follow soon thereafter," Fauci said. (158 comments)
Today's Markets
In Asia, Japan +0.86%. Hong Kong +0.73%. China +1.51%. India +0.12%.
In Europe, at midday, London -0.34%. Paris -0.11%. Frankfurt -0.32%.
Futures at 6:20, Dow -0.05%. S&P -0.06%. Nasdaq -0.08%. Crude -0.65% at $68.86. Gold -1.07% at $1814.15. Bitcoin -1.8% at $50940.
Ten-year Treasury Yield +4.3 bps to 1.365%
In Europe, at midday, London -0.34%. Paris -0.11%. Frankfurt -0.32%.
Futures at 6:20, Dow -0.05%. S&P -0.06%. Nasdaq -0.08%. Crude -0.65% at $68.86. Gold -1.07% at $1814.15. Bitcoin -1.8% at $50940.
Ten-year Treasury Yield +4.3 bps to 1.365%
Today's Economic Calendar
What else is happening...
Japan to purchase 150M doses of Novavax's (NASDAQ:NVAX) COVID-19 vaccine.
FDA places clinical hold on BioMarin's (NASDAQ:BMRN) Phase 1/2 gene therapy study in phenylketonuria.
HUYA's (NYSE:HUYA) chief financial officer resigns.
111 (NASDAQ:YI) approves $10M share repurchase program.
Deutsche Telekom (OTCQX:DTEGF) nears €5B sale of Dutch unit - Bloomberg.


Want More Ideas?
Our best ideas → Stock Ideas
ETF's Investing Ideas → ETF Ideas
Dividend stocks ideas → Dividend Ideas
This email was sent to you because you signed up to receive Wall Street Breakfast.
If you do not want to receive Wall Street Breakfast emails, click here to unsubscribe.
Sent by Seeking Alpha, 52 Vanderbilt Avenue, 13th floor, New York, NY 10017
EmoticonEmoticon